Order NO. D194016
小鼠抗CA19-9單克隆抗體（標記）
| 英文名 | Anti-CA19-9 mouse monoclonal antibody (labelling) | ||
| 別名 | Cancer Antigen 19-9; Carbohydrate Antigen 19-9; CA 19-9; CA19.9; sialylated Lewis a antigen; 癌抗原19-9; 糖鏈抗原19-9 | ||
| 相關類別 | 一抗 | 儲存 | 冷凍（-20℃） |
| 宿主 | Mouse | 反應種屬 | Reacts specifically with Sialyl Lewis a containing glycolipids, without detectable reactivity with Lewisa, Lewis b or structurally related substances as determined by solid-phase binding assays against glycolipid antigens. Shows minimal cross-reactivity (<1%) with Sialyl Lacto-N-tetraosylceramide |
| 標記物 | Unconjugate | 克隆類型 | mouse monoclonal |
| 抗原 | CA19-9 | ||
|
|||
| 編 號 | 包裝 | 庫存 | 目錄價（￥） | 您的價格（￥） | 數 量 |
| D194016-0001 | 1 MG | 預計5日內發貨 |  |
|
|
| D194016-0100 | 100 UG | 預計5日內發貨 | |
|
|
技術規格
| Background: | CA19-9 is a serum tumor marker for pancreatic cancer diagnosis. It is also used for monitoring therapy in patients with pancreatic adenocarcinoma. CA19-9 is synthesized by normal pancreatic and biliary ductal cells and by gastric, colon, endometrial and saliva epithelia. In a normal patient, it is present in small amounts in serum. The plasmatic levels of CA19-9 are greatly increased in neoplastic disease. |
| Applications: | Immunoassay, IHC |
| Name of antibody: | CA19-9 |
| Immunogen: | Human colorectal adenocarcinoma cell-line SW1116 |
| Full name: | Cancer Antigen 19-9 |
| Synonyms: | Carbohydrate Antigen 19-9; CA 19-9; CA19.9; sialylated Lewis a antigen |
相關文檔
 |
||||